Drugs / Grippol® Plus, trivalent (Yamagata lineage)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT03849560 Comparator | Nov 2016 → Jun 2017 | influenza | NPO Petrovax | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Grippol Plus, trivalent (Yamagata lineage) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03849560 ↗ |
| Route | Intramuscular | “Single intramuscular injection of 0.5 ml (1 dose) of vaccine Grippol® Plus, trivalent (Yamagata lineage)” NCT03849560 ↗ |